Efficacy of combined immunotherapy and predictive role of inflammatory markers in elderly ESCC patients
Combining ICIs with chemoradiotherapy improves survival in elderly inoperable ESCC patients. NLR and PNI may serve as accessible biomarkers to guide immunotherapy.
Authors
- Rui Luo (ORCID: https://orcid.org/0000-0001-5280-0999)
- Yangyang Ding (ORCID: https://orcid.org/0000-0003-1588-2571)
- Bailong Liu (ORCID: https://orcid.org/0000-0001-5112-7720)
- Xiaonan Pang (ORCID: https://orcid.org/0000-0003-2460-1970)
- Min Liu (ORCID: https://orcid.org/0000-0002-4641-7712)
- Junjie Liu (ORCID: https://orcid.org/0000-0002-8827-1141)
- Mengyu Liu (ORCID: https://orcid.org/0000-0002-6677-0046)
- Zhong Fan (ORCID: https://orcid.org/0000-0003-2632-011X)
- Gang Nie (ORCID: https://orcid.org/0000-0003-3667-6603)
Institutions
- Anhui Medical University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Future Science OA
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1080/20565623.2025.2564018
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00